US Stock MarketDetailed Quotes

AVBP ArriVent BioPharma

Watchlist
  • 23.990
  • -0.370-1.52%
Close Aug 19 16:00 ET
  • 23.990
  • 0.0000.00%
Post 16:06 ET
805.73MMarket Cap-10738P/E (TTM)

ArriVent BioPharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments
63.36%298.67M
--317.39M
-7.95%150.39M
-7.95%150.39M
--166.36M
--182.83M
338.23%163.37M
--163.37M
--37.28M
-Cash and cash equivalents
89.23%298.67M
--317.39M
-7.95%150.39M
-7.95%150.39M
--141.36M
--157.83M
338.23%163.37M
--163.37M
--37.28M
-Short-term investments
----
----
----
----
--25M
--25M
----
----
----
Receivables
190.70%750K
--875K
52.20%761K
52.20%761K
--1.09M
--258K
100.00%500K
--500K
--250K
-Taxes receivable
190.70%750K
--875K
52.20%761K
52.20%761K
--633K
--258K
100.00%500K
--500K
--250K
-Other receivables
----
----
----
----
--456K
----
----
----
----
Prepaid assets
-41.70%9.09M
--9.21M
-52.97%8.82M
-52.97%8.82M
--12.53M
--15.59M
245.81%18.75M
--18.75M
--5.42M
Total current assets
55.28%308.51M
--327.48M
-12.40%159.97M
-12.40%159.97M
--179.98M
--198.69M
325.18%182.62M
--182.62M
--42.95M
Non current assets
Net PPE
188.16%219K
--250K
109.35%291K
109.35%291K
--44K
--76K
--139K
--139K
--0
-Gross PPE
188.16%219K
--250K
109.35%291K
109.35%291K
--44K
--76K
--139K
--139K
--0
Non current deferred assets
--0
--0
--2.73M
--2.73M
--1.89M
----
--0
--0
----
Other non current assets
52.44%125K
--108K
48.61%107K
48.61%107K
--71K
--82K
-17.24%72K
--72K
--87K
Total non current assets
117.72%344K
--358K
1,383.41%3.13M
1,383.41%3.13M
--2.01M
--158K
142.53%211K
--211K
--87K
Total assets
55.33%308.86M
--327.84M
-10.79%163.1M
-10.79%163.1M
--181.99M
--198.84M
324.81%182.83M
--182.83M
--43.04M
Liabilities
Current liabilities
Payables
-40.97%3.81M
--4.1M
46.48%4.53M
46.48%4.53M
--4.82M
--6.46M
955.97%3.09M
--3.09M
--293K
-accounts payable
-40.97%3.81M
--4.1M
46.48%4.53M
46.48%4.53M
--4.82M
--6.46M
955.97%3.09M
--3.09M
--293K
Current accrued expenses
31.98%6.1M
--4.7M
46.24%3.6M
46.24%3.6M
--2.75M
--4.62M
302.12%2.46M
--2.46M
--612K
Current debt and capital lease obligation
100.00%152K
--147K
9.38%140K
9.38%140K
--44K
--76K
--128K
--128K
----
-Current capital lease obligation
100.00%152K
--147K
9.38%140K
9.38%140K
--44K
--76K
--128K
--128K
--0
Current liabilities
-5.58%12.1M
--9.98M
39.04%11.62M
39.04%11.62M
--10.1M
--12.81M
359.85%8.36M
--8.36M
--1.82M
Non current liabilities
Long term debt and capital lease obligation
--98K
--138K
1,509.09%177K
1,509.09%177K
--0
--0
--11K
--11K
--0
-Long term capital lease obligation
--98K
--138K
1,509.09%177K
1,509.09%177K
--0
--0
--11K
--11K
--0
Preferred securities outside stock equity
--0
--0
17.31%304.49M
17.31%304.49M
--304.49M
----
--259.57M
--259.57M
--0
Total non current liabilities
--98K
--138K
17.37%304.67M
17.37%304.67M
--304.49M
--0
--259.58M
--259.58M
--0
Total liabilities
-4.82%12.2M
--10.12M
18.04%316.29M
18.04%316.29M
--314.59M
--12.81M
14,638.28%267.94M
--267.94M
--1.82M
Shareholders'equity
Share capital
-100.00%3K
--3K
--0
--0
--0
--304.49M
--0
--0
--89.87M
-common stock
-25.00%3K
--3K
--0
--0
--0
--4K
--0
--0
--0
-Preferred stock
--0
--0
----
----
----
--304.49M
----
----
--89.87M
Retained earnings
-61.26%-197.14M
---175.26M
-78.33%-157.85M
-78.33%-157.85M
---136.65M
---122.25M
-71.51%-88.51M
---88.51M
---51.61M
Paid-in capital
12,935.69%493.79M
--492.98M
36.70%4.65M
36.70%4.65M
--4.15M
--3.79M
14.81%3.4M
--3.4M
--2.96M
Other equity interest
----
----
----
----
---106K
----
----
----
---2K
Total stockholders'equity
59.47%296.66M
--317.72M
-80.00%-153.19M
-80.00%-153.19M
---132.6M
--186.03M
-306.47%-85.11M
---85.11M
--41.22M
Total equity
59.47%296.66M
--317.72M
-80.00%-153.19M
-80.00%-153.19M
---132.6M
--186.03M
-306.47%-85.11M
---85.11M
--41.22M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Cash, cash equivalents and short term investments 63.36%298.67M--317.39M-7.95%150.39M-7.95%150.39M--166.36M--182.83M338.23%163.37M--163.37M--37.28M
-Cash and cash equivalents 89.23%298.67M--317.39M-7.95%150.39M-7.95%150.39M--141.36M--157.83M338.23%163.37M--163.37M--37.28M
-Short-term investments ------------------25M--25M------------
Receivables 190.70%750K--875K52.20%761K52.20%761K--1.09M--258K100.00%500K--500K--250K
-Taxes receivable 190.70%750K--875K52.20%761K52.20%761K--633K--258K100.00%500K--500K--250K
-Other receivables ------------------456K----------------
Prepaid assets -41.70%9.09M--9.21M-52.97%8.82M-52.97%8.82M--12.53M--15.59M245.81%18.75M--18.75M--5.42M
Total current assets 55.28%308.51M--327.48M-12.40%159.97M-12.40%159.97M--179.98M--198.69M325.18%182.62M--182.62M--42.95M
Non current assets
Net PPE 188.16%219K--250K109.35%291K109.35%291K--44K--76K--139K--139K--0
-Gross PPE 188.16%219K--250K109.35%291K109.35%291K--44K--76K--139K--139K--0
Non current deferred assets --0--0--2.73M--2.73M--1.89M------0--0----
Other non current assets 52.44%125K--108K48.61%107K48.61%107K--71K--82K-17.24%72K--72K--87K
Total non current assets 117.72%344K--358K1,383.41%3.13M1,383.41%3.13M--2.01M--158K142.53%211K--211K--87K
Total assets 55.33%308.86M--327.84M-10.79%163.1M-10.79%163.1M--181.99M--198.84M324.81%182.83M--182.83M--43.04M
Liabilities
Current liabilities
Payables -40.97%3.81M--4.1M46.48%4.53M46.48%4.53M--4.82M--6.46M955.97%3.09M--3.09M--293K
-accounts payable -40.97%3.81M--4.1M46.48%4.53M46.48%4.53M--4.82M--6.46M955.97%3.09M--3.09M--293K
Current accrued expenses 31.98%6.1M--4.7M46.24%3.6M46.24%3.6M--2.75M--4.62M302.12%2.46M--2.46M--612K
Current debt and capital lease obligation 100.00%152K--147K9.38%140K9.38%140K--44K--76K--128K--128K----
-Current capital lease obligation 100.00%152K--147K9.38%140K9.38%140K--44K--76K--128K--128K--0
Current liabilities -5.58%12.1M--9.98M39.04%11.62M39.04%11.62M--10.1M--12.81M359.85%8.36M--8.36M--1.82M
Non current liabilities
Long term debt and capital lease obligation --98K--138K1,509.09%177K1,509.09%177K--0--0--11K--11K--0
-Long term capital lease obligation --98K--138K1,509.09%177K1,509.09%177K--0--0--11K--11K--0
Preferred securities outside stock equity --0--017.31%304.49M17.31%304.49M--304.49M------259.57M--259.57M--0
Total non current liabilities --98K--138K17.37%304.67M17.37%304.67M--304.49M--0--259.58M--259.58M--0
Total liabilities -4.82%12.2M--10.12M18.04%316.29M18.04%316.29M--314.59M--12.81M14,638.28%267.94M--267.94M--1.82M
Shareholders'equity
Share capital -100.00%3K--3K--0--0--0--304.49M--0--0--89.87M
-common stock -25.00%3K--3K--0--0--0--4K--0--0--0
-Preferred stock --0--0--------------304.49M----------89.87M
Retained earnings -61.26%-197.14M---175.26M-78.33%-157.85M-78.33%-157.85M---136.65M---122.25M-71.51%-88.51M---88.51M---51.61M
Paid-in capital 12,935.69%493.79M--492.98M36.70%4.65M36.70%4.65M--4.15M--3.79M14.81%3.4M--3.4M--2.96M
Other equity interest -------------------106K---------------2K
Total stockholders'equity 59.47%296.66M--317.72M-80.00%-153.19M-80.00%-153.19M---132.6M--186.03M-306.47%-85.11M---85.11M--41.22M
Total equity 59.47%296.66M--317.72M-80.00%-153.19M-80.00%-153.19M---132.6M--186.03M-306.47%-85.11M---85.11M--41.22M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg